⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACXP News
Acurx Pharmaceuticals, Inc. Common Stock
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
prnewswire.com
ACXP
Form 8-K
sec.gov
ACXP
Approximately 20 million pets in the U.S. experience poverty with their families
prnewswire.com
ACXP
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
prnewswire.com
ACXP
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
prnewswire.com
ACXP
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)
accessnewswire.com
NTHI
CISO
NRXP
SNYR
DVLT
ACXP
AERT
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
accessnewswire.com
RDZN
NRXP
AERT
CISO
ACXP
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television
accessnewswire.com
DVLT
ACXP
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
prnewswire.com
ACXP
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
prnewswire.com
ACXP